Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Equity Ratio (2016 - 2025)

Organogenesis Holdings has reported Equity Ratio over the past 10 years, most recently at 0.5 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.5 for Q4 2025, down 5.07% from a year ago — trailing twelve months through Dec 2025 was 0.5 (down 5.07% YoY), and the annual figure for FY2025 was 0.5, down 5.07%.
  • Equity Ratio for Q4 2025 was 0.5 at Organogenesis Holdings, roughly flat from 0.5 in the prior quarter.
  • Over the last five years, Equity Ratio for ORGO hit a ceiling of 0.62 in Q3 2024 and a floor of 0.48 in Q1 2021.
  • Median Equity Ratio over the past 5 years was 0.56 (2022), compared with a mean of 0.55.
  • Biggest five-year swings in Equity Ratio: skyrocketed 234.05% in 2021 and later decreased 19.82% in 2025.
  • Organogenesis Holdings' Equity Ratio stood at 0.54 in 2021, then grew by 8.59% to 0.59 in 2022, then grew by 2.46% to 0.61 in 2023, then fell by 12.83% to 0.53 in 2024, then fell by 5.07% to 0.5 in 2025.
  • The last three reported values for Equity Ratio were 0.5 (Q4 2025), 0.5 (Q3 2025), and 0.51 (Q2 2025) per Business Quant data.